Clinical Trial Update: Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism [Phase 2]

View source ↗

Summary

Phase 2 placebo-controlled trial evaluating terpenes-enriched cannabis oil (T1/C28) for children with autism is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Terpenes-Enriched Cannabis Oil T1/C28 (terpenes-enriched cannabis oil)

Snippet

Sponsor: Bazelet Nehushtan LtD. | Conditions: Autism, Autism Spectrum Disorder | Phase 2 | Status: RECRUITING